Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim–Chester disease

Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim–Chester disease'. Together they form a unique fingerprint.

Medicine & Life Sciences